Evidence map›Paper›PMID 17982128›Full record

ArticleThe American journal of pathology2007

Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice.

James G Fox, Arlin B Rogers, Mark T Whary, Zhongming Ge, Masa Ohtani, Evelyn Kurt Jones, Timothy C Wang

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Subcellular Localization of the TFF Peptides xP1 and xP4 in theInternational journal of molecular sciences · 2020
    Article
  19. Article
  20. The TFF Peptides xP1 and xP4 Appear in Distinctive Forms in theInternational journal of molecular sciences · 2019
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. jgfox@mit.edu
Arlin B Rogers
Mark T Whary
Zhongming Ge
Masa Ohtani
Evelyn Kurt Jones
Timothy C Wang
Massachusetts Institute of Technology · USColumbia University · USUniversity of Massachusetts Chan Medical School · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
Reaction and Diffusion of NO in Biological SystemsP01CA026731 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI TANNENBAUM, STEVEN R · 1985 to 2018
$25.4M
HELIOBACTER INDUCED HEPATITIS AND TUMORIGENESISR01CA067529 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1995 to 2009
$3.2M
The Function and Regulation of Trefoil Factor Family 2 (TFF2)R01DK060758 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WANG, TIMOTHY CRAGIN · 2001 to 2011
$2.5M
NCI NIH HHS P01 CA026731NCI NIH HHS P01 CA26731NCI NIH HHS R01 CA067529NCI NIH HHS R01 CA67529NCI NIH HHS R01 CA87958NIAID NIH HHS R01 AI51404NIDDK NIH HHS R01 DK060758NIDDK NIH HHS R01 DK60758-07NIEHS NIH HHS P30 ES002109NIEHS NIH HHS P30 ES02109
6 · The paper itself

Abstract

Trefoil factor family 2 (TFF2) is up-regulated in Helicobacter spp.-infected gastric tissues of both humans and mice. To ascertain the biological effects of TFF2 in vivo, TFF2(-/-) C57BL/6 x Sv129 and wild-type (WT) C57BL/6 x Sv129 mice were orally infected with Helicobacter pylori SS1. Mice were evaluated for gastric H. pylori colonization, pathology, and cytokine profiles at 6 and 19 months post inoculation (pi). At 6 months pi, there was a significant difference (P < 0.05) for epithelial criteria (mucosal defects, atrophy, hyperplasia, pseudopyloric metaplasia, and dysplasia) in the corpus of TFF2(-/-) versus WT mice. At 19 months pi, a similar statistical difference in epithelial parameters was noted in the antrum of TFF2(-/-) versus WT mice (P < 0.01). All of the TFF2(-/-) H. pylori-infected mice had high-grade antral dysplasia, including gastric intraepithelial neoplasia, which was statistically significant (P < 0.05) compared with the infected WT mice. Levels of interferon-gamma were markedly elevated in the gastric mucosa of infected TFF2(-/-) mice at both 6 and 19 months pi. TFF2 provided a cytoprotective and/or anti-inflammatory effect against the progression of premalignant lesions of the gastric corpus at 6 months pi and in the pyloric antrum in H. pylori-infected mice at 19 months pi. These data support a protective role for TFF2 in part by modulating levels of gastric interferon-gamma in the development of H. pylori-associated premalignancy of the distal stomach.

Indexed as

AnimalsGastritisHelicobacter InfectionsHelicobacter pyloriHyperplasiaInterferon-gammaMetaplasiaMiceMice, Inbred C57BLMice, KnockoutMucinsMuscle ProteinsPeptidesPrecancerous ConditionsPyloric AntrumTrefoil Factor-2Interferon-gammaMucinsMuscle ProteinsPeptidesTFF2 protein, humanTFF2 protein, mouseTrefoil Factor-2

Identifiers

PMID17982128
PMCPMC2043513
OpenAlexW2025476651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.